| Financial Year |
March 31 2023 |
| Monetary Funds |
593,969,110.45 |
| Held-for-trading Financial Assets |
43,364,338.84 |
| Notes Receivable |
79,731,419.92 |
| Accounts Receivable |
634,264,700.71 |
| Advances to Suppliers |
31,127,638.64 |
| Other Receivables |
3,150,501.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,650,009,269.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
93,629,887.13 |
| Total Current Assets |
3,211,767,918.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,050,576.66 |
| Investment Properties |
41,368,298.05 |
| Fixed Assetes |
2,721,998,230.09 |
| Under-construction Projects |
1,213,212,601.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
345,420,617.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,203,610.09 |
| Deferred Income Tax Assets |
58,067,157.65 |
| Other Non-Current Assets |
445,217,937.11 |
| Sub-Total of Non-Current Assets |
4,865,378,750.23 |
| Total Assets |
8,077,146,669.07 |
| Short-Term Loans |
386,511,732.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
673,003,482.30 |
| Accounts Payable |
688,881,789.84 |
| Accounts Received In Advance |
5,343,603.47 |
| Employee Compensation Payable |
48,248,287.90 |
| Taxes Payable |
40,625,155.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,257,230.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
233,888,910.97 |
| Other Current Liabilities |
2,885,615.07 |
| Sub-Total of Current Liabilities |
2,134,069,735.27 |
| Long-term Loans |
1,162,342,496.70 |
| Bonds Payable |
561,012,378.16 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,952,209.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,780,638,080.62 |
| Total Liabilities |
3,914,707,815.89 |
| Paid-In Capital(Or Share Stock) |
892,926,322.00 |
| Capital Surplus |
1,256,350,155.62 |
| Surplus Reserve |
84,299,045.70 |
| LESS:Treasury Stock |
31,561,673.59 |
| Undistributed Profits |
1,898,827,560.50 |
| Minority Stockholder's Interest |
-1,832,591.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,164,271,444.67 |
| Owner's Equity（Stockholder's Equity） |
4,162,438,853.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,077,146,669.07 |
